Why are we doing this research?
Cincinnati Children’s is conducting a research study, sometimes known as a clinical trial or clinical study, to help us evaluate if the study drug tenofovir DF is effective and safe in the treatment of hepatitis B virus in children 2 to 11 years old. We also hope to learn about how kids’ bodies handle the study drug.
Who can participate?
Children 2 to 11 years old who have been diagnosed with chronic hepatitis B may be eligible to participate.
What are the good things that can happen from this research?
Being in the study may not help your child. However, your child will have close medical monitoring of his/her health condition. When we complete the study, we hope to know if the study drug tenofovir DF is effective in treating Hepatitis B in children 2 to 11 years old.
What are the bad things that can happen from this research?
Possible serious risks and discomforts to the child will be discussed with parents or guardians as part of the consenting process.
Will you/your child be paid to be in this research study?
Families may receive up to $1,200 for time and effort. If eligible, families may receive travel reimbursement.